Skip to content

The effects of intraabdominal pressure on perfusion values in obese and normal weight patients in laparoscopic cholecystectomy operation

The effects of pneumoperitoneum on Pleth Variability Index and Total Hemoglobin (SpHb) values in obese and normal weight patients in laparoscopic cholecystectomy operation

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620000169943
Enrollment
60
Registered
2020-02-17
Start date
2019-12-09
Completion date
2020-01-30
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

With the development of minimal-invasive techniques, laparoscopic procedures are the basis of general surgery. Artificial pneumoperitoneum is usually established by carbon dioxide insufflation and the intraabdominal pressure is frequently maintained between 10 and 15 mmHg. There are two ways to monitor this volume status: invasive and non-invasive. Non-invasive plethysmographic variability index (PVI) and Total hemoglobin (SpHb) are new parameters used for fluid response in surgical patients. Although these two parameters have been shown to be affected by pneumoperitoneum in laparoscopic surgery, the role of obesity has not been established. These parameters were evaluated in gastric bypass operations to evaluate the effects of pneumoperitoneum in obese patients and their changes were evaluated. However, there are no studies evaluating obese patients and normal weight patients with the same operation type and the same abdominal pressure values. Our aim in this study was to determine how PVI and SpHb are affected by pneumoperitoneum in obese and normal weight patients.

Interventions

Patients undergoing laparoscopic cholecystectomy will undergo a masimo finger probe (a probe like saturation probe that measures non invasively pleth variability index, perfusion index, hg levels from hand finger) prior to surgery. With this probe, PVI and SpHb values will be measured. 10-12 mmHg pneumoperitoneum will be formed by laparoscopy tower according to the routine procedure of laparoscopic surgeries after the patient is anesthetized (every laparoscopic cholecystectomy operation needs pn

Patients undergoing laparoscopic cholecystectomy will undergo a masimo finger probe (a probe like saturation probe that measures non invasively pleth variability index, perfusion index, hg levels from hand finger) prior to surgery. With this probe, PVI and SpHb values will be measured. 10-12 mmHg pneumoperitoneum will be formed by laparoscopy tower according to the routine procedure of laparoscopic surgeries after the patient is anesthetized (every laparoscopic cholecystectomy operation needs pneumoperitoneum for clear vision by laparoscopic camera). Pneumoperitoneum will be performed with CO2 by general surgeon. Changes in the PVI and SpHb values measured from the Masimo finger probe will be recorded. Duration of interventions will be aproximately 60 minutes. Operations lasting longer than 60 minutes will be excluded from the study.

Sponsors

Gulcin Patmano
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Other
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

ASA (American Society of Anesthesiologists) 1-2 patiens patients undergoing lararoscopic cholecystectomy Study Group: body mass index > 30 Control Group : body mass index < 30

Exclusion criteria

ASA 3-4 patients patients who refused to participate in the study pregnancy intraoperative bleeding over 100 ml

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026